Searched for
WINDLAS BIOTECH SHARES
Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record dateWindlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The ...- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Sensex falls! But these stocks are up over 15% on BSEIn the Nifty50 index, 29 stocks were trading in the green, while 21 stocks were in the red.
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeRico Auto, Kalyani Steels, Windlas Biotech, The Hi-Tech Gears and Yuken India, hit their fresh 52-week highs during the day.
- Windlas Biotech rallies 19% on concluding EU inspection with zero critical observationThe recently listed pharmaceuticals player said it has concluded European Union's good manufacturing practice inspection carried out by the...
- PGIM India Mutual Fund buys stake in Kolte-Patil DevelopersIn another transaction, Kuber India Fund sold 113,468 shares of Windlas Biotech at Rs. 379.7 apiece through a bulk deal on the NSE.
- Nuvoco Vistas debuts at discount to IPO on weak market moodThe Rs 5,000-crore IPO of Nuvoco got a tepid response from investors. The IPO was subscribed 1.71 times. The portion set aside for qualifie...
- No IPO magic for CarTrade, loses 7.3% on debut dayThe shares that were issued at ₹1,618 each opened trading at ₹1,600 on the BSE and fell to a low of ₹1,476 in early trade before closing at...
- Devyani lists at 56% premium to IPO price, others witness muted debutsShares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...
- Windlas Biotech lists at 5% discount to issue priceThe IPO by the Dehradun-based pharma formulations company ran from August 4 to August 6 and was sold in the Rs 448-460 range.
- IPO grey market getting its mojo back after BSE clarificationPremia of these listing candidates in the unofficial market were hammered badly after sentiment in the second rung stocks took a hit, subsc...
- Windlas Biotech IPO: Here's how to check allotment statusThe three-day IPO received bids for 13,77,39,750 shares against 61,36,252 shares on offer, as per NSE data.
- Windlas Biotech IPO subscribed 7 times on Day 2Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...
- IPO Street’s paved with gold? Retail investors can’t stop buyingThe average listing day gains of five IPOs in July was 76%. Tatva Chintan Pharma listed at a premium of 113%, GR Infraprojects rallied 109%...
- Windlas Biotech IPO sails through on day 1 of biddingThe Rs 401 crore issue received applications for 63,38,730 shares out of on-offer 61,36,252 shares, meaning a subscription of slightly over...
- Windlas Biotech offers its shares at 64x PE. Should you subscribe?The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...
- 4 IPOs going to leave you spoilt for choice: Should you go all in?They include Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech, which are going to raise close to Rs 3,614 crore ...
- 4 IPOs to keep market buzzing this week; to raise Rs 3,600 croreAnalysts and traders expect the issues to sail through given the demand for fresh issues in the market. The grey market premium has also ju...
- Windlas Biotech IPO opens on Aug 4, price band fixed at Rs 448-460Windlas Biotech will raise Rs 165 crore through the issuance of fresh equity shares, while promoters and existing shareholders will offload...
- Windlas Biotech files draft papers for IPOThe company is into domestic pharmaceutical formulations contract development and manufacturing business.
Load More
